LAB vs WELL · rev $174.4M vs P/E 100, rev $10.84B
Standard Biotools Inc (LAB) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
LAB currently screens at market cap $317.1M. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the LAB and WELL stock pages for the full models.
Not investment advice.